Epizyme (EPZM) Misses Q1 EPS by 3c

Epizyme (NASDAQ: EPZM) reported Q1 EPS of ($0.38), $0.03 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $10.42 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15